Other

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period

Accenture Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period remained flat by 0.0% to 1.9M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.4%, from 1.8M to 1.9M. Over 4 years (FY 2021 to FY 2025), Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period shows an upward trend with a 2.7% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ4 2025Oct 10, 2025

How to read this metric

A high volume of grants may signal aggressive talent acquisition or retention strategies, but also implies future dilution for shareholders.

Detailed definition

The total number of equity instruments, such as stock options or restricted shares, granted to employees during the repo...

Peer comparison

Standard disclosure for companies using equity as a primary component of total compensation.

Metric ID: other_share_based_compensation_arrangement_by_share_base_cb4be8

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value6.9M6M8.9M7.2M7.6M
YoY Change-11.9%+47.4%-19.4%+6.4%
Range6M8.9M
CAGR+2.7%
Avg YoY Growth+5.6%
Median YoY Growth-2.7%

Frequently Asked Questions

What is Accenture's share based compensation arrangement by share based payment award equity instruments other than options grants in period?
Accenture (ACN) reported share based compensation arrangement by share based payment award equity instruments other than options grants in period of 1.9M in Q2 2025.
How has Accenture's share based compensation arrangement by share based payment award equity instruments other than options grants in period changed year-over-year?
Accenture's share based compensation arrangement by share based payment award equity instruments other than options grants in period increased by 6.4% year-over-year, from 1.8M to 1.9M.
What is the long-term trend for Accenture's share based compensation arrangement by share based payment award equity instruments other than options grants in period?
Over 4 years (2021 to 2025), Accenture's share based compensation arrangement by share based payment award equity instruments other than options grants in period has grown at a 2.7% compound annual growth rate (CAGR), from 6.9M to 7.6M.
What does share based compensation arrangement by share based payment award equity instruments other than options grants in period mean?
The total volume of shares or stock awards given to employees as part of their compensation package.